Dental M&A in 2026: More Selective Deals, Tighter Terms, and a Shifting Seller Market
Dental M&A is entering a more disciplined phase in 2026. Sixty-nine percent of DSOs expect to increase acquisitions this year, but a high-demand, low-supply environment is limiting available targets, according to TUSK Practice Sales’ Q2 2026 Dental Market Report. Deals are facing greater scrutiny — DSOs are walking away over staffing risk, over-reliance on a single producer, and weak practice performance projections, with a minimum 5-year post-close employment term now increasingly required. De novo growth is gaining appeal as an acquisition alternative, and private equity remains active — particularly in oral surgery. Several states where more than 40% of active dentists are aged 55 or older represent a potential seller wave that could shift the market dynamic later this year.
The “growth at any cost” DSO era is over. Operators evaluating practice acquisitions or planning a sale need to understand that buyers are now prioritizing operational quality, clinical continuity, and regional density over topline size — and that deal terms have gotten materially more demanding.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.